Galectin-3 in Patients With Paroxysmal and Persistent Atrial Fibrillation and Metabolic Syndrome
| Autor: | Elena Baranova, E. Zaslavskaya, Nrady Ao, S E Nifontov, Evgeny Shlyakhto, O. V. Listopad, A. V. Soboleva, A Va |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Adult
Male 0301 basic medicine medicine.medical_specialty Galectin 3 Galectins 03 medical and health sciences Internal medicine Atrial Fibrillation otorhinolaryngologic diseases Humans Medicine In patient Aged Paroxysmal AF Metabolic Syndrome business.industry Atrial fibrillation Blood Proteins Middle Aged medicine.disease 030104 developmental biology Galectin-3 Persistent atrial fibrillation Clinical value Cardiology Female Myocardial fibrosis Metabolic syndrome Cardiology and Cardiovascular Medicine business Anti-Arrhythmia Agents Biomarkers |
| Zdroj: | Kardiologiia. :41-45 |
| ISSN: | 0022-9040 |
| DOI: | 10.18565/cardio.2016.6.17-22 |
| Popis: | OBJECTIVE To evaluate serum galectin 3 and to determine the potential clinical value of this parameter in patients with atrial fibrillation - AF (paroxysmal and persistent) and metabolic syndrome (MS). DESIGN AND METHODS We examined 100 patients with MS (50 with paroxysmal or persistent AF and 50 without arrhythmia) and 50 healthy persons. Serum galectin 3 measured by ELISA method, ECHO cardiography was performed to all examined persons. RESULTS Galectin 3 in patients with MS and AF was higher, than in patients with MS without arrhythmia and much more higher than galectin 3 in healthy persons 0,72 (0,44;1,36), 0,44 (0,42;1,22) and 0,32 (0,28;0,42) ng/ml ( |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|